November 17, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549
Attention: Margaret Schwartz
Re: |
| Aravive, Inc. |
|
| Registration Statement on Form S-3 |
|
| File No. 333-248612 |
Ladies and Gentlemen:
Aravive, Inc. (the “Company”) hereby requests that the effective date of the Company’s Registration Statement on Form S-3 (File No. 333-248612), be accelerated by the U.S. Securities and Exchange Commission to Friday, November 20, 2020 at 9:00 a.m., Eastern Time, or as soon as reasonably practicable thereafter.
The Company hereby authorizes its legal counsel, Leslie Marlow and/or Patrick Egan of Gracin & Marlow, LLP, to orally modify or withdraw this request for acceleration. Please contact Ms. Marlow at (516) 496-2223 or (212) 907-6457 or Mr. Egan at (914) 557-5574 with any questions you may have concerning this request, and please notify either of them when this request for acceleration has been granted.
| Very truly yours, | |
|
|
|
| Aravive, Inc. | |
|
|
|
| By: | /s/ Vinay Shah |
|
| Name: Vinay Shah |
|
| Title: Chief Financial Officer |
cc: Leslie Marlow, Esq.
Patrick J. Egan, Esq.